The Inflammatory Response to Transcatheter Aortic Valve Replacement
JACC: Cardiovascular Interventions · 2025-11 · 18 (22) · 2685-2700
DOI: 10.1016/j.jcin.2025.09.023 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JACC: Cardiovascular Interventions, 2025-11. Verfasst von Annette Maznyczka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department of Cardiology, Leeds Teaching Hosp…. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Inflammation, Aortic Valve, Aortic Valve Stenosis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Inflammation is common in response to transcatheter aortic valve replacement (TAVR), resulting from endothelial damage, procedure-related hypoperfusion, and immunogenicity against the bioprosthesis. The systemic inflammatory response after TAVR comprises a spectrum ranging from asymptomatic biomarker elevation to dramatic clinical manifestations. Although local inflammation post-TAVR is part of physiological healing, a hyperinflammatory response increases the risk for conduction disturbances, new-onset atrial fibrillation, acute kidney injury, prolonged hospitalization, mortality, and subclinical leaflet thrombosis. Unfavorable monocyte and T helper cell signatures can predispose to worse outcomes in connection with hyperinflammation. Strategies are needed to control key drivers of hyperinflammation after TAVR (eg, avoiding prolonged hypotension during transcatheter aortic valve deployment, periprocedural colchicine or glucocorticoids, targeted monoclonal antibodies, a healthy gut microbiome) and to identify patients in whom modulation of inflammatory pathways may optimize outcomes. This review provides a detailed description of the epidemiology, pathophysiology, and consequences of the inflammatory response to TAVR and discusses emerging treatment pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom. Electronic address: amaznyczka…
- The Heart Center, Rigshospitalet, Copenhagen, Denmark.
- Department of Cardiology, Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA.
- Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
- Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: thomas.pilgrim@insel.ch.
Zitieren
APA
Maznyczka, A., De Backer, O., Généreux, P., Blackman, D. J., & Pilgrim, T. (2025). The Inflammatory Response to Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions, 18(22), 2685-2700. https://doi.org/10.1016/j.jcin.2025.09.023
Vancouver
Maznyczka A, De Backer O, Généreux P, Blackman DJ, Pilgrim T. The Inflammatory Response to Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 2025;18(22):2685-2700. doi:10.1016/j.jcin.2025.09.023
BibTeX
@article{Maznyczka2025,
author = {Maznyczka, Annette and De Backer, Ole and Généreux, Philippe and Blackman, Daniel J and Pilgrim, Thomas},
title = {The Inflammatory Response to Transcatheter Aortic Valve Replacement},
journal = {JACC: Cardiovascular Interventions},
year = {2025},
volume = {18},
number = {22},
pages = {2685--2700},
doi = {10.1016/j.jcin.2025.09.023}
}
EUVIMED